Back to Search Start Over

Anemarrhena asphodeloides Bunge total saponins ameliorate diabetic cardiomyopathy by modifying the PI3K/AKT/HIF-1α pathway to restore glycolytic metabolism.

Authors :
Zhong, Luyang
Li, Jianhua
Yu, Jiamin
Cao, Xia
Du, Jieyong
Liang, Lanyuan
Yang, Mengru
Yue, Yimin
Zhao, Mantong
Zhou, Tong
Lin, Jiazi
Wang, Xiao
Shen, Xuejuan
Zhong, Yanmei
Wang, Yi
Shu, Zunpeng
Source :
Journal of Ethnopharmacology. Jan2024:Part 3, Vol. 319, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

Based on the theory of traditional Chinese medicine (TCM), diabetic cardiomyopathy (DCM) belongs to the category of " Xiaoke disease" according to the symptoms, and "stasis-heat" is the main pathogenesis of DCM. The Chinese medicine Anemarrhena asphodeloides Bunge (AAB), as a representative of heat-clearing and engendering fluid, is often used clinically in the treatment of DCM. Anemarrhena asphodeloides Bunge total saponins (RATS) are the main bioactive components of AAB, the modern pharmacologic effects of RATS are anti-inflammatory, hypoglycemic, and cardioprotective. However, the potential protective mechanisms of RATS against DCM remain largely undiscovered. The primary goal of this study was to explore the effect of RATS on DCM and its mechanism of action. Streptozotocin and a high-fat diet were used to induce DCM in rats. UHPLC/Q-TOF-MS was used to determine the chemical components of RATS. The degenerative alterations and apoptotic cells in the heart were assessed by HE staining and TUNEL. Network pharmacology was used to anticipate the probable targets and important pathways of RATS. The alterations in metabolites and main metabolic pathways in heart tissue were discovered using 1 H-NMR metabolomics. Ultimately, immunohistochemistry was used to find critical pathway protein expression. First of all, UHPLC/Q-TOF-MS analysis showed that RATS contained 11 active ingredients. In animal experiments, we found that RATS lowered blood glucose and lipid levels in DCM rats, and alleviated cardiac pathological damage, and decreased cardiomyocyte apoptosis. Furthermore, the study found that RATS effectively reduced inflammatory factor release and the level of oxidative stress. Mechanistically, RATS downregulated the expression levels of PI3K, AKT, HIF-1α, LDHA, and GLUT4 proteins. Additionally, glycolysis was discovered to be a crucial pathway for RATS in the therapy of DCM. Our findings suggest that the protective effect of RATS on DCM may be attributed to the inhibition of the PI3K/AKT/HIF-1 α pathway and the correction of glycolytic metabolism. [Display omitted] • We found for the first time that the Anemarrhena asphodeloides Bunge total saponins could improve diabetes cardiomyopathy. • We discuss the chemical composition, pharmacological action, and mechanism of Anemarrhena asphodeloides Bunge total saponins. • We found that Anemarrhena asphodeloides Bunge total saponins could improve diabetes cardiomyopathy by regulating glycolytic metabolism. • We provide theoretical guidance for the application of Anemarrhena asphodeloides Bunge total saponins in modern medicine. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03788741
Volume :
319
Database :
Academic Search Index
Journal :
Journal of Ethnopharmacology
Publication Type :
Academic Journal
Accession number :
173696806
Full Text :
https://doi.org/10.1016/j.jep.2023.117250